GHRH: Cognition in Aging and MCI.
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2016
At a glance
- Drugs Tesamorelin (Primary)
- Indications Mild cognitive impairment
- Focus Therapeutic Use
- Acronyms SMART
- 31 Aug 2018 Biomarkers information updated
- 21 Dec 2013 NCT reports actual patient number as 151.
- 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.